Cadila Healthcare has signed the Definitive Agreement for sale of 2,31,33,717 equity shares of Rs 10 each fully paid?up, representing 49% of the total paid?up share capital of Windlass Healthcare (WHPL) to Windlas Biotech (WBPL). The board of the company at its meeting held on April 30, 2020, approved the same.
Consequent to above divestment and upon completion of the transaction in relation to the sale of the said equity shares, the company shall cease to hold any equity shares in WHPL. The transaction is expected to be completed within 10 business days.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
